Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

New funding for NHS research projects

May 28, 2009 Research and Development NHS

Projects ranging from diagnostics to diabetes care and genotyping have been given government funding as part of a new award …
News

Johnson & Johnson to buy Cougar Biotechnology

May 27, 2009 Research and Development, Sales and Marketing Cougar, J&J, JJ

Johnson & Johnson is to buy Los Angeles-based biotech firm Cougar Biotechnology for $970 million.The purchase, expected to go through …
News

UK government ignores biotech pleas for cash

May 27, 2009 Research and Development biotech

The UK biotech sector says the government's failure to provide urgently needed financial assistance is jeopardising its future.Industry body the …
News

Quotient buys Scottish clinical unit from Charles River

May 26, 2009 Research and Development Charles River, Quotient

Contract research organisation Quotient Bioresearch has acquired a facility from Charles River Laboratories that will boost its capabilities in the …
News

Phase III drug superior to Spiriva, says Novartis

May 21, 2009 Research and Development, Sales and Marketing COPD, Novarits

Novartis says its COPD treatment has shown significant benefits over two established rivals, and could form the cornerstone of a …
News

Mexican flu: contained but not beaten

May 21, 2009 Research and Development Mexico, Vaccine, flu, pandemic

Global efforts to limit the impact of the new strain of H1N1 flu virus have proven successful, but the threat …
Feature

Takeda to market new bone cancer drug

May 20, 2009 Research and Development, Sales and Marketing MA, Takeda

Takeda has gained the rights to the first treatment for a new malignant bone cancer affecting children and young adults. …
News

Cannabis-derived MS drug filed for European approval

May 20, 2009 Research and Development, Sales and Marketing GW, Sativex

Sativex, the cannabis-derived product developed by GW Pharmaceuticals, could be finally set for European approval after five years of delay. …
News

EFPIA plans counterfeit crackdown

May 20, 2009 Manufacturing and Production, Research and Development EFPIA, counterfeits

 European pharmaceutical industry association EFPIA has unveiled a new scheme to crack down on counterfeit medicines.Beginning with a trial run …
News

SkyePharma cuts staff at French and Swiss facilities

May 20, 2009 Research and Development, Sales and Marketing Skyepharma

SkyePharma has moved ahead with plans to cut its workforce at a manufacturing plant in France by a third as …
News

The medical-marketing interface and how to bridge the gap

May 18, 2009 Research and Development, Sales and Marketing marketing, medical

Drug companies are not charities and are accountable to their shareholders, as we all know. Products have to be sold …
Feature

GSK signs oncology deal with UK biotech

May 18, 2009 Research and Development, Sales and Marketing GSK, Oxford Biotherapeutics

GSK has struck a deal with Oxford BioTherapeutics to develop therapies for primary, metastatic and recurring forms of cancer. The …
News

Sanofi-Aventis signs deal with Japanese biotech

May 15, 2009 Research and Development, Sales and Marketing Sanofi-Aventis

Sanofi-Aventis has signed an early-stage research deal with biotech Kyowa Hakko Kirin, and will receive rights to its preclinical stage …
News

Kendle trims down as profits slump

May 15, 2009 Research and Development Kendle

Contract research organisation Kendle joined many of its peers in reporting a slump in demand for its clinical research services …
News

Boehringer signs diabetes and obesity deal

May 14, 2009 Research and Development, Sales and Marketing Boehringer

Boehringer Ingelheim has signed a deal with German biopharma firm DeveloGen to research and develop treatments for diabetes and obesity. …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026